Clinical, Endoscopic, and Histopathology Features of Esophageal Graft-vs-Host Disease.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35311761.
- Also identified by DOI 10.14309/ajg.0000000000001738.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To describe the clinical, endoscopic, and histopathology features of esophageal graft-vs-host disease (GVHD). Patients with biopsy-proven esophageal GVHD diagnosed at Mayo Clinic between 2000 and 2021 were included. In 43 esophageal patients, other organ GVHD was present in 58% before and 86% at esophageal GVHD diagnosis. Esophageal specific symptoms were uncommon (dysphagia 26% and odynophagia/heartburn 5%). Esophagogastroduodenoscopy was abnormal in 72% patients demonstrating erosive esophagitis, ulceration, desquamation, or rings/furrows in a diffuse or focal pattern. There should be a low threshold for esophageal biopsies for GVHD because esophageal symptoms and endoscopic findings may be nonspecific or absent.
Medical subject headings
- Deglutition Disorders
- Esophagitis
- Graft vs Host Disease